Bora Group Posts Record 2Q26 Revenue and Strong Profits as Margins expand and Operations Resume Demand-Driven Growth
HONG KONG SAR - Media OutReach Newswire – 13 August 2026 – Bora Pharmaceuticals ("Bora"; TWSE: 6472; OTCQX: BORAY) today announced its financial results and operational highlights for 2Q2026 and provides full year outlook update . 2Q26 Business and Financial Highlights Bora delivered historically record-high quarterly revenues of NT$5,889 million in 2Q26, up 47.2% quarter-over-quarter driven by…
Bora Pharmaceuticals announced record high quarterly revenues of NT$5,889 million in the second quarter of 2026, a 47.2% increase from the previous quarter. Basic earnings per share (EPS) reached NT$4.36 for the quarter. The company's gross margin expanded to 41.3% from 36.0% and operating margin hit 16.8% from 10.2% in the first quarter of the same year.
Written by urgent.news from Arabian Post's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
